Publicaciones de los grupos de investigación: junio 2011

Pediatría

Rives S, Estella J, Gómez P, López Duarte M, De Miguel PG, Verdeguer A, Moreno MJ, Vivanco JL, Couselo JM, Fernández Delgado R, Maldonado M, Tasso M, López Ibor B, Lendínez F, López Almaraz R, Uriz J, Melo M, Fernández Teijeiro A, Rodríguez I, Badell I. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. Br J Haematol 2011 :in print. Factor de impacto:  4,942.

Enfermedades infecciosas e inmunopatología infantil

García M, Santiago JL, Terrón A, Hernández Martín A, Vicente A, Fortuny C, De Lucas R, López JC, Cuadrado N, Holguín A, Illera N, Duarte B, Sánchez Jimeno C, Llames S, García E, Ayuso C, Martínez Santamaría L, Castiglia D, De Luca N, Torrelo A, Mechan D, Baty D, Zambruno G, Escámez MJ, Del Río M. Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol 2011 :in print. Factor de impacto:  4,351.

Morén C, Noguera A, Rovira N, Corrales E, Garrabou G, Hernández S, Nicolás M, Tobías E, Cardellach F, Miró O, Fortuny C. Mitochondrial Impact of Human Immunodeficiency Virus and Antiretrovirals on Infected Pediatric Patients With or Without Lipodystrophy. Pediatr Infect Dis J 2011 :in print. Factor de impacto:  3,064.

Muñoz Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolomé R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J Infect 2011 :in print. Factor de impacto:  3,060.

Selva L, Krauel X, Pallares R, Muñoz Almagro C. Easy diagnosis of invasive pneumococcal disease. Emerg Infect Dis 2011 ;17 (6) :1125-27. Factor de impacto:  6,859.

Enfermedades del adulto con origen fetal o en los primeros años de vida

Ibáñez L, López Bermejo A, Díaz M, Marcos MV, De Zegher F. Early Metformin Therapy (Age 8-12 Years) in Girls with Precocious Pubarche to Reduce Hirsutism, Androgen Excess, and Oligomenorrhea in Adolescence. J Clin Endocrinol Metab 2011 :in print. Factor de impacto:  6,495.

Iriondo M, Szyld E, Vento M, Burón E, Salguero E, Aguayo J, Ruiz C, Elorza D, Thió M. Grupo de reanimación neonatal de la Sociedad Española de Neonatología. Adaptación de las recomendaciones internacionales sobre reanimación neonatal 2010: comentarios. An Pediatr (Barc) 2011 :in print. Factor de impacto:  0,363.

Jin W, Goldfine AB, Boes T, Henry RR, Ciaraldi TP, Kim EY, Emecan M, Fitzpatrick C, Sen A, Shah A, Mun E, Vokes V, Schroeder J, Tatro E, Jiménez Chillarón J, Patti ME. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest 2011 ;121 (3) :918-29. Factor de impacto:  15,387.

Desarrollo neuronal y enfermedades metabólicas

Arrabal L, Teresa L, Sánchez Alcudia R, Castro M, Medrano C, Gutiérrez Solana L, Roldán S, Ormazábal A, Pérez Cerdá C, Merinero B, Pérez B, Artuch R, Ugarte M, Desviat LR. Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant. Neurogenetics 2011 :in print. Factor de impacto:  3,486.

Kölker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, Burlina AP, Dixon M, Duran M, García Cazorla A, Goodman SI, Koeller DM, Kyllerman M, Mühlhausen C, Müller E, Okun JG, Wilcken B, Hoffmann GF, Burgard P. Diagnosis and management of glutaric aciduria type I - revised recommendations. J Inherit Metab Dis 2011 ;34 (3) :677-94. Factor de impacto:  3,598.

López Laso E, Sánchez Raya A, Moriana JA, Martínez Gual E, Camino León R, Mateos González ME, Pérez Navero JL, Ochoa JJ, Ormazábal A, Opladen T, Klein C, Lao JI, Beyer K, Artuch R. Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease. J Neurol 2011 :in print. Factor de impacto:  2,903.

Pérez Poyato M, Pineda M. New agents and approaches to treatment in niemann - pick type C disease. Curr Pharm Biotechnol 2011 ;12 (6) :897-901. Factor de impacto:  3,404.

Vega AI, Pérez Cerdá C, Abia D, Gámez A, Briones P, Artuch R, Desviat LR, Ugarte M, Pérez B. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG) : Expression analysis of PMM2-CDG mutations. J Inherit Metab Dis 2011 :in print. Factor de impacto:  3,598.

Biología molecular de los tumores en desarrollo

Elmeliegy MA, Montero Carcaboso A, Tagen M, Bai F, Stewart CF. Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation. Clin Cancer Res 2011 ;17 (1) :89-99. Factor de impacto:  6,747.

Nemeth KM, Federico S, Montero Carcaboso A, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C, Dyer MA. Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma. Cancer 2011 ;117 (2) :421-34. Factor de impacto:  5,418.